General Request for Proposals – ADDF

ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF)

Objecte

Topic: Alzheimer.

Destination: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias.

Budget:

  • Drug development: up to $600,000
  • Program to accelerate clinical trials : up to $3 million
  • Neuroimaging and CSF biomarker development program: up to $600,000
  • Prevention pipeline: up to $3 million for clinical trials

Duration:

  • Drug development: 1 year, potential for follow-up funding.
  • Program to accelerate clinical trials: multi-year, potential for follow-up funding.
  • Neuroimaging and CSF biomarker development program: 1 year, potential for follow-up funding. Multi-year proposals can be considered.
  • Prevention pipeline: multi-year, potential for follow-up funding.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: